Two Sigma Securities, LLC Oragenics Inc Transaction History

Two Sigma Securities, LLC

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	SELL	$0.11 - $15.59 $565 - $80,085	-5,137 Reduced 17.53%	24,162 $2,000
Q3 2022 Nov 14, 2022	BUY	$0.23 - $14.18 $6,738 - $415,459	29,299 New	29,299 $7,000
Q2 2022 Aug 15, 2022	SELL	$0.24 - $0.42 $7,263 - $12,710	-30,263 Closed	0 $0
Q1 2022 May 16, 2022	SELL	$0.33 - $0.56 $12,619 - $21,414	-38,240 Reduced 55.82%	30,263 $10,000
Q4 2021 Feb 14, 2022	BUY	$0.43 - $0.69 $29,456 - $47,267	68,503 New	68,503 $31,000
Q2 2021 Aug 16, 2021	SELL	$0.6 - $0.89 $6,411 - $9,510	-10,686 Closed	0 $0
Q1 2021 May 17, 2021	SELL	$0.52 - $1.52 $6,820 - $19,936	-13,116 Reduced 55.1%	10,686 $10,000
Q4 2020 Feb 16, 2021	BUY	$0.39 - $0.6 $9,282 - $14,281	23,802 New	23,802 $11,000
Q3 2019 Nov 14, 2019	SELL	$0.36 - $0.64 $13,209 - $23,483	-36,693 Closed	0 $0
Q2 2019 Aug 14, 2019	BUY	$0.46 - $0.6 $16,878 - $22,015	36,693 New	36,693 $18,000
Q1 2019 May 15, 2019	SELL	$0.57 - $1.05 $7,261 - $13,377	-12,740 Closed	0 $0
Q4 2018 Feb 14, 2019	SELL	$0.78 - $3.57 $29,123 - $133,296	-37,338 Reduced 74.56%	12,740 $11,000
Q3 2018 Nov 14, 2018	BUY	$0.38 - $1.42 $19,029 - $71,110	50,078 New	50,078 $58,000

Ticker OGEN
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 116,395,000
Market Cap $36.1M
Description
Oragenics, Inc. develops antibiotics for infectious diseases in the United States. The company engages in the development and commercialization of NT-CoV2-1, an intranasal vaccine candidate that provides immunity from the novel severe acute respiratory syndrome coronavirus; and Terra CoV-2, an intramuscular vaccine candidate that provides immuni...

Get notified when there are updates to the investment portfolio of Two Sigma Securities, LLC, based on Form 13F filings with the SEC.

Stay updated on Two Sigma Securities, LLC with notifications on news.